902 Views | 331 Downloads
Address correspondence to Rafi Ahmed, rahmed@emory.edu.
Present address: Donald R. Latner and Rachael D. Aubert, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; William A. Langley, Medical Neurogenetics LLC, Atlanta, Georgia, USA; Sang-Jun Ha, Department of Biochemistry, College of Life Science and Engineering, Yonsei Univeristy, Seoul, South Korea; Surojit Sarkar and Vandana Kalia, Department of Veterinary and Biomedical Sciences, College of Agricultural Sciences, Penn State University, University Park, Pennsylvania, USA.
We thank the NIH tetramer core facility (Emory University, Atlanta, GA) for providing MHC class II tetramer IAb-gp66-77 for LCMV.
We thank Rama S. Akondy for careful reading of the manuscript.
W.J.L. and R.S. are inventors on patents and patent applications related to IL-21.
This work was supported by National Institutes of Health (NIH) grants P01 AI097092-01A1; (to R.A.) and RO1 A1030048 (to R.A.) and Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery grant UM1AI100663 (to R.A.).
This work was also supported in part by the Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH (to W.J.L. and R.S.).
© 2013, American Society for Microbiology. All Rights Reserved.